Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 1,318,991 | 1,226,800 | 1,220,122 | 1,212,629 | 1,200,849 |
| Cost of Goods | 84,168 | 74,687 | 44,228 | 69,033 | 111,752 |
| Gross Profit | 1,234,823 | 1,152,112 | 1,175,894 | 1,143,596 | 1,089,097 |
| Operating Expenses | 804,449 | 805,838 | 813,320 | 852,001 | 760,541 |
| Operating Income | 430,542 | 346,962 | 362,802 | 291,628 | 329,308 |
| Interest Expense | 7,501 | 2,813 | 496 | 1,251 | 2,640 |
| Other Income | 9,248 | -2,637 | 3,575 | 1,879 | 3,483 |
| Pre-tax Income | 432,289 | 341,512 | 365,881 | 292,256 | 330,151 |
| Income Tax | 183,358 | 88,419 | 101,077 | 96,038 | 148,766 |
| Net Income Continuous | 248,931 | 253,093 | 264,804 | 196,218 | 181,385 |
| Net Income | $248,931 | $253,093 | $264,804 | $196,218 | $181,385 |
| EPS Basic Total Ops | 2.36 | 2.40 | 2.53 | 1.88 | 1.74 |
| EPS Basic Continuous Ops | 2.36 | 2.41 | 2.53 | 1.88 | 1.74 |
| EPS Diluted Total Ops | 2.16 | 2.15 | 2.27 | 1.69 | 1.59 |
| EPS Diluted Continuous Ops | 2.16 | 2.15 | 2.27 | 1.69 | 1.59 |
| EBITDA(a) | $468,657 | $375,817 | $390,641 | $316,657 | $352,285 |